perfluorobutane has been researched along with Adenocarcinoma in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kudo, N; Kumara, WR; Lim, SY; Murakami, M; Nakamura, K; Ohta, H; Sasaki, N; Takiguchi, M; Tamura, Y; Yamasaki, M | 1 |
Akasu, G; Fukuyo, K; Goto, Y; Kawahara, R; Kinoshita, H; Okuda, K; Sakai, T; Sato, T; Tanaka, H; Yasumoto, M | 1 |
Bzyl, J; Grouls, C; Kiessling, F; Lederle, W; Palmowski, M; Penzkofer, T; Pochon, S; Rix, A; Schneider, M; Siepmann, M; Tardy, I | 1 |
3 other study(ies) available for perfluorobutane and Adenocarcinoma
Article | Year |
---|---|
Activation of microbubbles by short-pulsed ultrasound enhances the cytotoxic effect of cis-diamminedichloroplatinum (II) in a canine thyroid adenocarcinoma cell line in vitro.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Cisplatin; Contrast Media; Dogs; Drug Synergism; Ferric Compounds; High-Energy Shock Waves; Iron; Microbubbles; Oxides; Thyroid Neoplasms; Treatment Outcome | 2012 |
Clinicopathological analysis of contrast-enhanced ultrasonography using perflubutane in pancreatic adenocarcinoma.
Topics: Actins; Adenocarcinoma; Adult; Aged; Antigens, CD34; Contrast Media; Disease-Free Survival; Female; Fluorocarbons; Humans; Hypoxia; Male; Microbubbles; Microcirculation; Middle Aged; Muscle, Smooth; Neoplasms; Pancreatic Neoplasms; Time Factors; Ultrasonography | 2012 |
Molecular and functional ultrasound imaging in differently aggressive breast cancer xenografts using two novel ultrasound contrast agents (BR55 and BR38).
Topics: Adenocarcinoma; Animals; Breast Neoplasms; Contrast Media; Disease Models, Animal; Female; Fluorocarbons; Humans; Immunohistochemistry; Mice; Mice, Nude; Microbubbles; Molecular Biology; Neovascularization, Pathologic; Nitrogen; Random Allocation; Reference Values; Sensitivity and Specificity; Transplantation, Heterologous; Ultrasonography, Doppler; Vascular Endothelial Growth Factor Receptor-2 | 2011 |